v3.26.3
Income Taxes - Schedule of Deferred Tax Assets and Deferred Tax Liabilities (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Net operating loss carry forwards $ 9,878,482 $ 9,032,440
Capitalization of research and development expenses 1,516,763 1,806,909
Stock option expense 883,261 541,476
Warrant expense 465,230 465,230
Accrued expenses 101,337 50,797
Depreciation and amortization (2,463) (2,796)
Research and development tax credit 1,377,283 1,170,784
Valuation allowance (14,219,893) (13,064,840)
Net deferred tax asset